Fotiou, D., Sergentanis, T. N., Papageorgiou, L., Stamatelopoulos, K., Gavriatopoulou, M., Kastritis, E., . . . Gerotziafas, G. T. (2018). Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: Results of the prospective ROADMAP-MM-CAT study. Blood Cancer J.
Citación estilo ChicagoFotiou, Despina, et al. "Longer Procoagulant Phospholipid-dependent Clotting Time, Lower Endogenous Thrombin Potential and Higher Tissue Factor Pathway Inhibitor Concentrations Are Associated With Increased VTE Occurrence in Patients With Newly Diagnosed Multiple Myeloma: Results of the Prospective ROADMAP-MM-CAT Study." Blood Cancer J 2018.
Cita MLAFotiou, Despina, et al. "Longer Procoagulant Phospholipid-dependent Clotting Time, Lower Endogenous Thrombin Potential and Higher Tissue Factor Pathway Inhibitor Concentrations Are Associated With Increased VTE Occurrence in Patients With Newly Diagnosed Multiple Myeloma: Results of the Prospective ROADMAP-MM-CAT Study." Blood Cancer J 2018.